Aspart
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2692 publications
Treprostinil Inhalation Powder for Pulmonary Arterial Hypertension: Evidence and Clinical Positioning Among Inhaled Formulations.
Journal: The Annals of pharmacotherapy
Published: October 30, 2026
Therapeutic advances in pulmonary fibrosis.
Journal: Therapeutic advances in respiratory disease
Published: October 24, 2026
In brief: An expanded indication for Afrezza.
Journal: The Medical letter on drugs and therapeutics
Published: October 18, 2026
Treatment of pulmonary fibrosis: Beginning of a new era
Journal: Pneumologie (Stuttgart, Germany)
Published: October 08, 2026
Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis.
Journal: The New England journal of medicine
Published: October 07, 2026
Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis.
Journal: The New England journal of medicine
Published: October 07, 2026
Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis. Reply.
Journal: The New England journal of medicine
Published: October 07, 2026
Pulmonary hypertension in interstitial lung disease: today's realities, tomorrow's possibilities.
Journal: Minerva medica
Published: September 10, 2026
Real-World Experience of Midodrine in Hospital Setting in Pulmonary Arterial Hypertension.
Journal: CHEST pulmonary
Published: September 03, 2026
Efficacy and Safety of Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.
Journal: Advances in respiratory medicine
Published: August 19, 2026
Effect of Cyclodextrin Complexation on the Separation of Insulin Analogues in Capillary Electrophoresis Using Dynamically Coated Capillaries.
Journal: Molecules (Basel, Switzerland)
Published: August 01, 2026
Last Updated: 11/08/2026